(Updated - December 3, 2025 6:40 AM EST)

Leerink Partners analyst Joseph Schwartz downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE